Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T00:58:46.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T19:55:31.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about a clinical trial for non-small cell lung cancer, including its title, sponsor, and last update date. Additionally, the page emphasizes that the U.S. government does not review or approve all studies listed.
    Difference
    81%
    Check dated 2025-08-02T14:42:29.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page has undergone significant deletions, including a service alert about planned maintenance that will affect service availability for over 24 hours, and a disclaimer regarding the review of studies listed on the site.
    Difference
    46%
    Check dated 2025-07-26T12:26:07.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.3%
    Check dated 2025-07-19T11:06:15.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    4%
    Check dated 2025-07-12T07:27:51.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.